Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
gptkb:1449271-14-6
|
| gptkbp:developedBy |
gptkb:National_Cancer_Institute
|
| gptkbp:hasMolecularFormula |
C20H19N3O2
|
| https://www.w3.org/2000/01/rdf-schema#label |
NDI-034858
|
| gptkbp:investigatedBy |
gptkb:cancer
solid tumors |
| gptkbp:IUPACName |
N-(4-(1H-indol-3-yl)butyl)-1H-indole-2-carboxamide
|
| gptkbp:mechanismOfAction |
PARP inhibitor
|
| gptkbp:molecularWeight |
333.39 g/mol
|
| gptkbp:synonym |
NCI-034858
NDI034858 |
| gptkbp:bfsParent |
gptkb:Nimbus_Therapeutics
|
| gptkbp:bfsLayer |
7
|